Monoclonal antibody demonstrates ‘unprecedented’ virologic suppression in HIV study

[From Healio, April 17, 2019]

“The monoclonal antibody UB-421 “demonstrated unprecedented and sustained” virologic suppression in the absence of ART among people with HIV during a nonrandomized, open-label, phase 2 clinical study, according to findings published today by The New England Journal of Medicine.”

For more, click here.

Leave a Comment

Scroll to Top